Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. The current political, economic, and social environment presents both opportunities for and challenges to strengthening the U.S. system for developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services.
Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. The book makes recommendations about priority actions in the update to the National Vaccine Plan that are intended to achieve the objectives of disease prevention and enhancement of vaccine safety. It is centered on the plan's five goals in the areas of vaccine development, safety, communication, supply and use, and global health.
Table of Contents
|1 Development of New and Improved Vaccines||31-50|
|2 The Safety of Vaccines and Vaccination Practices||51-78|
|3 Informed Vaccine Decision Making||79-96|
|4 Vaccine Supply and Use||97-120|
|5 Vaccines and Global Health||121-138|
|Appendix A: Draft Strategic National Vaccine Plan||153-238|
|Appendix B: Letter to the Committee from the National Vaccine Advisory Committee||239-242|
|Appendix C: 1986 National Childhood Vaccine Injury Act (Public Law 99-660)||243-272|
|Appendix D: Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office||273-312|
|Appendix E: History of Public Engagement at the National Vaccine Program Office||313-316|
|Appendix F: Agendas of Stakeholder Meetings Held by the Committee on Review of Priorities in the National Vaccine Plan (July 2008-June 2009)||317-344|
|Appendix G: Acronyms||345-348|
|Appendix H: Committee Biographies||349-356|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Priorities for the National Vaccine Plan...